The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

The GA4GH is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care ...

In resource-limited settings, genomic assays for hormone receptor-positive, HER2-negative breast cancer aren't always ...

Ellen Thomas, Chief Medical Officer of Genomics England, discusses key milestones and the future impact of genomics on ...

Graduate students Stephen Benz and Zack Sanborn and postdoctoral researcher Jing Zhu, all from the Haussler lab, were key members of the team that developed the UCSC Cancer Genomics Browser. Photo by ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

Although large-scale genomic databases can help researchers investigate cancer outcomes, regulatory barriers often stand in their way, wrote Jonathan Hirsch, co-founder of precision oncology company ...

Genomic profiling has ushered in a “revolution in cancer care” that has led to a doubling of survival rates for some terminally ill patients and sparked a radical acceleration in drug development.

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).

GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The ...

Researchers at ACTREC, Mumbai, have identified genetic factors causing early onset of oral cancer in tobacco chewers. Their ...